Find a TenderAwarded without competitionContract details notice
Published 27 Feb 2026, 12:20 GMT

Official UK procurement notice

Supply, Installation, Validation and Verification of Tandem Mass Spectrometer – Liquid Chromatography System

Official notice

Authority: Cambridge University Hospitals NHS Foundation Trust (Central government)

Direct award
Awarded value£415,800published award · exc. VAT
Awarded 11 Mar 2026no call for competition
Awarded to AB Sciex UK Limited

What is being bought

Published requirement description

Supply of a high sensitivity Tandem Mass Spectrometer – High Performance Liquid Chromatography system to Cambridge University Hospitals (CUH) for analysis of hormones biological fluids

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
27 Feb 2026, 12:20 GMT
Last source update
31 Mar 2026, 11:33 BST
Authority reference
ADD/PU/EW/25/54
FTS notice number
2026/S 000-029537
Latest notice
Contract details notice (UK7)
Delivery area
East of England (UKH)
Official registry OCID
ocds-h6vhtk-065e31 Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

The CUH Blood Sciences Endocrine Laboratory is looking to replace a high sensitivity Triple Quadrupole Tandem Mass Spectrometer (TMS) coupled to an ultra-high pressure liquid chromatography (HPLC) system. This system runs 10 methods that were developed in-house.

The Blood Sciences labs currently have four Sciex triple quadrupole tandem mass spectrometers (TMS) linked to Shimadzu or Sciex (Exion) liquid chromatography (HPLC) systems. This includes the system that we are replacing. The combined laboratories currently process around 120,000 samples a year through the four LC-Tandem Mass Spectrometer systems. Results generated from the systems are from technically/clinically validated methods and are used for diagnosis of endocrine and metabolic disorders, as well as for neonatal screening tests.

The replacement system will be capable of quantitation of a range of hormones or metabolites in human serum, urine and saliva. Some of the analytes are at pmol/L concentrations in human serum e.g. aldosterone/metanephrines, so a high sensitivity system is essential. The TMS – HPLC system must have the following critical elements:

TMS

  • The TMS will have multiple modes of operation including multiple reaction monitoring and scan modes. Scan modes must include precursor ion scan, product ion scan, neutral loss scan.
  • The TMS must be capable of Atmospheric Pressure Chemical Ionisation (APCI) and electrospray (ESI) ionisation modes with proven use of APCI for clinical hormone analyses.
  • The TMS must be capable of positive and negative modes.
  • The TMS must be capable of polarity switching within a sample acquisition run with a minimum settling time of 5msec between polarities.
  • The TMS must accept a fluid flow rate from 5µL/min to 3000µL/min, without flow splitting.
  • To allow for future development needs the TMS must have an option to be upgraded to a linear ion trap system that will provide additional scan modes such as MRM3, Enhanced Product Ion Scan.
  • The MS must have an integral infusion pump under full control of the system software to allow infusion rates up to 30µL/min to allow compound tuning and for ion suppression testing.
  • The MS control software must be compatible with multi-vendor HPLC systems e.g. Shimadzu, Agilent, Waters.
  • The system must be capable of the self-generation of all gases required for routine use (i.e. no requirement for a gas cylinder in the lab).
  • A suitable roughing pump must be supplied. This must be an oil-free pump.
  • Results must be able to be exported in .txt format to allow uploading to our current hospital information system.
  • Current methods in use in the Endocrine Lab must be directly transferrable without the need for re-development.

HPLC

  • The HPLC system must have a dual binary pump arrangement allowing pressures up to 10,000PSI. This setup is to allow online solid phase extraction using 2-position valves.
  • There must be a minimum of 4 solvent lines per pump with inline degassers. If binary pumps are proposed, there must be 4 solvent lines for each side of the binary pump. The LC must have the ability to switch to different solvent input lines, analytical columns without operator intervention to allow running of multiple assays to be processed consecutively.
  • The HPLC autosampler must be capable of injecting from 1 to 50µL.
  • The HPLC autosampler must have at least six positions for plate/vials and must be able to inject from 96 shallow well plates, 96 deep well plates and vials. It must be capable of using these in combination without changing hardware configuration.
  • The column oven must have an operating temperature range of 5 to 85°C.
  • The column oven and must be able to accommodate six analytical columns of 25cm length.
  • The column oven must be able to accommodate and drive 2, 7-port 6-position valves to allow switching between columns and therefore multiplexing of analytical methods.
  • The system must be able to drive 3 2-position 6-port valves independently to allow sequential running of different methods using online solid phase extraction.

The Trust believes that only Sciex 6500+ Tandem Mass Spectrometer, in conjunction with Shimadzu dual binary HPLC, can fulfil all of the essential criteria stated, and that only this equipment will allow rapid direct transfer of our current methods without the need to re-develop them.

How it was run

Official notice
Submission deadline
—

Timeline

23 Mar 2026 → 31 Mar 2026 · 2 dates
  1. Standstill ends216 days ago
    23 Mar 2026, 23:59 GMT
  2. Notice published209 days ago
    31 Mar 2026, 11:33 BST

Notice history

4 events · 3 releases on Find a Tender · since 27 Feb 2026
  1. Transparency notice published
    27 Feb 2026, 12:20 GMT
    UK5
  2. Contract award notice published
    11 Mar 2026, 11:42 GMT
    UK6
  3. Contract details notice published
    31 Mar 2026, 11:33 BST
    UK7
  4. Contract signature expected
    31 Mar 2026, 23:59 BST
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded value £415,8001 award exc. VAT
Contracts signed 1latest 23 Mar 2026
Awarded toValueDateStatus
AB Sciex UK Limited1 May 2026 – 30 Apr 2027£415,80011 Mar 2026Awarded

Contracts

  • Contract 1 · AB Sciex UK Limited

    Signed
    23 Mar 2026
    Value
    £415,490
    Period
    1 May 2026 – 30 Apr 2027
    Status
    active

    No agreed KPIs: Contract value is less than £5 million

Contracting authority & participating public bodies

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

Contracting authorityPublic authority - central government GB-NHS: RGT Hills Road, Cambridge, East of England, CB2 0QQContact name, email, phone

Bidders & participating suppliers

1 commercial party on the notice
  • AB Sciex UK LimitedAwarded supplierGB-COH: 07007374 Suite 21F18, 21 Mereside, Alderley Park, Macclesfield, North West, SK10 4TGContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

  • Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender
  • Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender
  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender